InvoCare share price rises on acquisitions announcement

The InvoCare Ltd (ASX: IVC) share price is one to watch in early trade after two new acquisitions from the Aussie funeral operator.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The InvoCare Limited (ASX: IVC) share price is one to watch this morning after the company's latest acquisition update.

a woman

What did InvoCare announce this morning?

The Aussie funeral company has entered into 2 separate sales agreements for business on the southern New South Wales coast.

InvoCare will acquire the business and assets of Batemans Bay and Moruya District Funerals as well as Broulee Memorial Gardens. The company expects to complete the purchases by the end of November.

The InvoCare share price has already lifted 1.48% in early trade to $13.68 per share.

Batemans Bay & Moruya District Funerals operates from 3 locations in Batemans Bay, Moruya and Narooma. The company performed over 400 funerals every year with annual revenue of $3 million.

Broulee Memorial Gardens performs 380 cremations per year including chapel services and memorialisation.

There was no dollar amount provided by InvoCare in the announcement regarding acquisition cost.

Where is the InvoCare share price headed this morning?

InvoCare shareholders have reacted to the news in early trade this morning, with the company's share price lifting 1.48% at time of writing. Acquirers' shares often trade heavily in the period after announcing an acquisition and this could be the case even with the smaller targets.

The company's shares also closed 0.97% higher on Monday at $13.48 per share as the S&P/ASX 200 Index (INDEXASX: XJO) hit a 3-month high.

How has the InvoCare share price performed this year?

The InvoCare share price has rocketed more than 32% higher so far this year to significantly outperform the ASX 200.

The Aussie funeral home operator has also managed to outpace fellow ASX competitor Propel Funeral Partners Ltd (ASX: PFP). The Propel share price is up 21.12% so far this year as the ASX Healthcare sector has had a strong 2019 performance.

Foolish takeaway

I'd expect to see continued movement from the InvoCare share price during morning trade following this acquisition news.

InvoCare is currently trading at a 36x earnings multiple with a tidy 2.71% net dividend yield.

Motley Fool contributor Kenneth Hall has no position in any of the stocks mentioned. The Motley Fool Australia has recommended InvoCare Limited and Propel Funeral Partners Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Doctor analysing x-rays.
Healthcare Shares

4DMedical shares are rocketing 11% today. Is a short squeeze starting?

Short sellers may be feeling the heat after this week’s rally.

Read more »

Medical workers examine an x-ray or scan in a hospital laboratory.
Healthcare Shares

Shares surge as ASX biotech charts road to redemption

A recent major setback might not be so bad.

Read more »

Young doctor raising arms in air with hands in fists celebrating a new development.
Healthcare Shares

Forget CSL shares, I'd buy this ASX biotech stock instead

Brokers tip this other ASX biotech stock to climb up to 76% higher.

Read more »

A male doctor wearing a white lab coat shrugs his shoulders and holds his hands up in the air looking confused.
Healthcare Shares

CSL acknowledges "disappointing" results but aims to do better

The search for a new CEO also goes on.

Read more »

A scientist in a white coat and glasses puts her arms in the air in a sign of strength and success.
Healthcare Shares

CSL, Resmed, and more. See which ASX health stocks RBC Capital Markets has upgraded

This sector is coming back into favour.

Read more »

a biomedical researcher sits at his desk with his hand on his chin, thinking and giving a small smile with a microscope next to him and an array of test tubes and beackers behind him on shelves in a well-lit bright office.
Healthcare Shares

4DMedical vs Telix Pharmaceuticals: ASX health tech share showdown

4DMedical and Telix are both Aussie health innovators—here’s which ASX share gets my vote in this biotech battle.

Read more »

cochlear happy, share price rise, up, increase
Healthcare Shares

Cochlear share price rebounds 53% from 10-year low: Can it keep climbing?

The shares are still down 47% for the year to date.

Read more »

Donor donates blood in medical clinic. Beautiful European woman of 30 years sits in medical chair looking into camera and smiling.
Healthcare Shares

Two broker upgrades put CSL shares back in focus

CSL is back on the radar after two broker upgrades.

Read more »